Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$6.05M
12 trades · 5 insiders
Net · 90d
$-6.05M
Insiders on file
11
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Karlin Daniel | Chief Medical Officer, Director | 10 | $0 | $1.39M | 2026-09-25 |
| Barrow Robert | Chief Executive Officer, Director | 14 | $0 | $5.52M | 2026-09-25 |
| Wiley Matthew T. | Chief Commercial Officer | 9 | $0 | $355.6K | 2026-09-25 |
| Roberts Brandi | Chief Financial Officer | 9 | $0 | $382.7K | 2026-09-25 |
| Sullivan Mark | Chief Legal Officer | 10 | $0 | $1.81M | 2026-09-25 |
| Krebs Andreas | Director | 6 | $0 | $0 | 2026-09-18 |
| Vallone Carol A | Director | 6 | $0 | $0 | 2026-09-18 |
| Adsett Roger | Director | 3 | $0 | $0 | 2026-06-11 |
| CRYSTAL ROGER | Director | 2 | $0 | $0 | 2026-06-11 |
| Bruhn Suzanne Louise | Director | 2 | $0 | $0 | 2026-06-11 |
| GRYSKA DAVID W | Director | 2 | $0 | $0 | 2026-06-11 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Roberts Brandi | Chief Financial Officer | S Sale | 2026-09-25 | 2026-09-29 | 3,377 | $36.57 | $123.5K | 394,528 | SEC↗ |
| Sullivan Mark | Chief Legal Officer | S Sale | 2026-09-25 | 2026-09-29 | 14,051 | $36.57 | $513.8K | 494,228 | SEC↗ |
| Wiley Matthew T. | Chief Commercial Officer | S Sale | 2026-09-25 | 2026-09-29 | 3,097 | $36.57 | $113.3K | 359,036 | SEC↗ |
| Barrow Robert | Chief Executive Officer | S Sale | 2026-09-25 | 2026-09-29 | 31,550 | $36.57 | $1.15M | 2,213,090 | SEC↗ |
| Karlin Daniel | Chief Medical Officer | S Sale | 2026-09-25 | 2026-09-29 | 10,853 | $36.57 | $396.9K | 792,846 | SEC↗ |
| Karlin Daniel | Chief Medical Officer, Direc | S Sale | 2026-09-25 | 2026-09-29 | 10,853 | $36.57 | $396.9K | 792,846 | SEC↗ |
| Wiley Matthew T. | Chief Commercial Officer | S Sale | 2026-09-25 | 2026-09-29 | 3,097 | $36.57 | $113.3K | 359,036 | SEC↗ |
| Sullivan Mark | Chief Legal Officer | S Sale | 2026-09-25 | 2026-09-29 | 14,051 | $36.57 | $513.8K | 494,228 | SEC↗ |
| Roberts Brandi | Chief Financial Officer | S Sale | 2026-09-25 | 2026-09-29 | 3,377 | $36.57 | $123.5K | 394,528 | SEC↗ |
| Barrow Robert | Chief Executive Officer, Dir | S Sale | 2026-09-25 | 2026-09-29 | 31,550 | $36.57 | $1.15M | 2,213,090 | SEC↗ |
| Vallone Carol A | Director | M Exercise deriv | 2026-09-18 | 2026-09-18 | 1,086 | — | $0 | 0 | SEC↗ |
| Krebs Andreas | Director | M Exercise deriv | 2026-09-18 | 2026-09-18 | 1,629 | — | $0 | 0 | SEC↗ |
| Vallone Carol A | Director | M Exercise | 2026-09-18 | 2026-09-18 | 1,086 | $35.52 | $38.6K | 22,296 | SEC↗ |
| Krebs Andreas | Director | M Exercise | 2026-09-18 | 2026-09-18 | 1,629 | $35.52 | $57.9K | 21,402 | SEC↗ |
| Krebs Andreas | Director | M Exercise deriv | 2026-09-18 | 2026-09-18 | 1,629 | — | $0 | 0 | SEC↗ |
| Krebs Andreas | Director | M Exercise | 2026-09-18 | 2026-09-18 | 1,629 | $35.52 | $57.9K | 21,402 | SEC↗ |
| Vallone Carol A | Director | M Exercise deriv | 2026-09-18 | 2026-09-18 | 1,086 | — | $0 | 0 | SEC↗ |
| Vallone Carol A | Director | M Exercise | 2026-09-18 | 2026-09-18 | 1,086 | $35.52 | $38.6K | 22,296 | SEC↗ |
| Barrow Robert | Chief Executive Officer | A Award | 2026-09-14 | 2026-09-14 | 750,000 | — | $0 | 2,244,640 | SEC↗ |
| Roberts Brandi | Chief Financial Officer | A Award | 2026-09-14 | 2026-09-14 | 125,000 | — | $0 | 397,905 | SEC↗ |
| Sullivan Mark | Chief Legal Officer | A Award | 2026-09-14 | 2026-09-14 | 125,000 | — | $0 | 508,279 | SEC↗ |
| Wiley Matthew T. | Chief Commercial Officer | A Award | 2026-09-14 | 2026-09-14 | 125,000 | — | $0 | 362,133 | SEC↗ |
| Karlin Daniel | Chief Medical Officer | A Award | 2026-09-14 | 2026-09-14 | 200,000 | — | $0 | 803,699 | SEC↗ |
| Karlin Daniel | Chief Medical Officer | A Award | 2026-09-14 | 2026-09-14 | 200,000 | — | $0 | 803,699 | SEC↗ |
| Wiley Matthew T. | Chief Commercial Officer | A Award | 2026-09-14 | 2026-09-14 | 125,000 | — | $0 | 362,133 | SEC↗ |
| Sullivan Mark | Chief Legal Officer | A Award | 2026-09-14 | 2026-09-14 | 125,000 | — | $0 | 508,279 | SEC↗ |
| Roberts Brandi | Chief Financial Officer | A Award | 2026-09-14 | 2026-09-14 | 125,000 | — | $0 | 397,905 | SEC↗ |
| Barrow Robert | Chief Executive Officer, Dir | A Award | 2026-09-14 | 2026-09-14 | 750,000 | — | $0 | 2,244,640 | SEC↗ |
| Barrow Robert | Chief Executive Officer | S Sale | 2026-09-03 | 2026-09-04 | 19,023 | $37.94 | $721.7K | 1,494,640 | SEC↗ |
| Barrow Robert | Chief Executive Officer, Dir | S Sale | 2026-09-03 | 2026-09-04 | 19,023 | $37.94 | $721.7K | 1,494,640 | SEC↗ |
| Barrow Robert | Chief Executive Officer | A Award | 2026-09-02 | 2026-09-04 | 40,000 | — | $0 | 1,513,663 | SEC↗ |
| Barrow Robert | Chief Executive Officer, Dir | A Award | 2026-09-02 | 2026-09-04 | 40,000 | — | $0 | 1,513,663 | SEC↗ |
| Roberts Brandi | Chief Financial Officer | A Award | 2026-08-12 | 2026-08-12 | 62,500 | — | $0 | 271,987 | SEC↗ |
| Wiley Matthew T. | Chief Commercial Officer | A Award | 2026-08-12 | 2026-08-12 | 62,500 | — | $0 | 237,133 | SEC↗ |
| Sullivan Mark | Chief Legal Officer | A Award | 2026-08-12 | 2026-08-12 | 62,500 | — | $0 | 383,071 | SEC↗ |
| Karlin Daniel | Chief Medical Officer | A Award | 2026-08-12 | 2026-08-12 | 100,000 | — | $0 | 603,282 | SEC↗ |
| Barrow Robert | Chief Executive Officer | A Award | 2026-08-12 | 2026-08-12 | 375,000 | — | $0 | 1,473,246 | SEC↗ |
| Karlin Daniel | Chief Medical Officer | A Award | 2026-08-12 | 2026-08-12 | 100,000 | — | $0 | 603,282 | SEC↗ |
| Sullivan Mark | Chief Legal Officer | A Award | 2026-08-12 | 2026-08-12 | 62,500 | — | $0 | 383,071 | SEC↗ |
| Wiley Matthew T. | Chief Commercial Officer | A Award | 2026-08-12 | 2026-08-12 | 62,500 | — | $0 | 237,133 | SEC↗ |
| Roberts Brandi | Chief Financial Officer | A Award | 2026-08-12 | 2026-08-12 | 62,500 | — | $0 | 271,987 | SEC↗ |
| Barrow Robert | Chief Executive Officer, Dir | A Award | 2026-08-12 | 2026-08-12 | 375,000 | — | $0 | 1,473,246 | SEC↗ |
| Wiley Matthew T. | Chief Commercial Officer | S Sale | 2026-06-25 | 2026-06-26 | 2,867 | $45.03 | $129.1K | 174,633 | SEC↗ |
| Barrow Robert | Chief Executive Officer | S Sale | 2026-06-25 | 2026-06-26 | 29,208 | $45.03 | $1.32M | 1,098,246 | SEC↗ |
| Roberts Brandi | Chief Financial Officer | S Sale | 2026-06-25 | 2026-06-26 | 3,013 | $45.03 | $135.7K | 209,487 | SEC↗ |
| Karlin Daniel | Chief Medical Officer | S Sale | 2026-06-25 | 2026-06-26 | 10,035 | $45.03 | $451.9K | 503,282 | SEC↗ |
| Sullivan Mark | Chief Legal Officer | S Sale | 2026-06-25 | 2026-06-26 | 13,008 | $45.03 | $585.8K | 320,571 | SEC↗ |
| Karlin Daniel | Chief Medical Officer | A Award | 2026-06-22 | 2026-06-22 | 100,000 | — | $0 | 513,317 | SEC↗ |
| Sullivan Mark | Chief Legal Officer | A Award | 2026-06-22 | 2026-06-22 | 62,500 | — | $0 | 333,579 | SEC↗ |
| Roberts Brandi | Chief Financial Officer | A Award | 2026-06-22 | 2026-06-22 | 62,500 | — | $0 | 212,500 | SEC↗ |
| Wiley Matthew T. | Chief Commercial Officer | A Award | 2026-06-22 | 2026-06-22 | 62,500 | — | $0 | 177,500 | SEC↗ |
| Barrow Robert | Chief Executive Officer | A Award | 2026-06-22 | 2026-06-22 | 375,000 | — | $0 | 1,127,454 | SEC↗ |
| Bruhn Suzanne Louise | Director | A Award deriv | 2026-06-11 | 2026-06-15 | 19,188 | — | $0 | 19,188 | SEC↗ |
| Adsett Roger | Director | A Award deriv | 2026-06-11 | 2026-06-15 | 14,620 | — | $0 | 14,620 | SEC↗ |
| Krebs Andreas | Director | A Award deriv | 2026-06-11 | 2026-06-15 | 19,188 | — | $0 | 19,188 | SEC↗ |
| Vallone Carol A | Director | A Award deriv | 2026-06-11 | 2026-06-15 | 19,188 | — | $0 | 19,188 | SEC↗ |
| GRYSKA DAVID W | Director | A Award deriv | 2026-06-11 | 2026-06-15 | 19,188 | — | $0 | 19,188 | SEC↗ |
| CRYSTAL ROGER | Director | A Award deriv | 2026-06-11 | 2026-06-15 | 19,188 | — | $0 | 19,188 | SEC↗ |
| Bruhn Suzanne Louise | Director | A Award | 2026-06-11 | 2026-06-15 | 4,666 | — | $0 | 24,289 | SEC↗ |
| Adsett Roger | Director | A Award | 2026-06-11 | 2026-06-15 | 3,555 | — | $0 | 3,555 | SEC↗ |
| Krebs Andreas | Director | A Award | 2026-06-11 | 2026-06-15 | 4,666 | — | $0 | 19,773 | SEC↗ |
| Vallone Carol A | Director | A Award | 2026-06-11 | 2026-06-15 | 4,666 | — | $0 | 21,210 | SEC↗ |
| GRYSKA DAVID W | Director | A Award | 2026-06-11 | 2026-06-15 | 4,666 | — | $0 | 19,900 | SEC↗ |
| CRYSTAL ROGER | Director | A Award | 2026-06-11 | 2026-06-15 | 4,666 | — | $0 | 24,289 | SEC↗ |
| Barrow Robert | Chief Executive Officer | S Sale | 2026-03-25 | 2026-03-26 | 24,431 | $18.47 | $451.2K | 752,454 | SEC↗ |
| Sullivan Mark | Chief Legal Officer | S Sale | 2026-03-25 | 2026-03-26 | 10,702 | $18.47 | $197.7K | 271,079 | SEC↗ |
| Karlin Daniel | Chief Medical Officer | S Sale | 2026-03-25 | 2026-03-26 | 8,018 | $18.47 | $148.1K | 413,317 | SEC↗ |
| Barrow Robert | Chief Executive Officer | A Award | 2026-02-03 | 2026-02-05 | 320,000 | — | $0 | 1,098,477 | SEC↗ |
| Karlin Daniel | Chief Medical Officer | A Award | 2026-02-03 | 2026-02-05 | 150,000 | — | $0 | 575,025 | SEC↗ |
| Sullivan Mark | Chief Legal Officer | A Award | 2026-02-03 | 2026-02-05 | 125,000 | — | $0 | 407,576 | SEC↗ |
| Roberts Brandi | Chief Financial Officer | A Award | 2026-02-03 | 2026-02-05 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Wiley Matthew T. | Chief Commercial Officer | A Award | 2026-02-03 | 2026-02-05 | 115,000 | — | $0 | 115,000 | SEC↗ |
| Adsett Roger | Director | A Award deriv | 2026-01-29 | 2026-01-29 | 50,000 | — | $0 | 50,000 | SEC↗ |